Zak, M., Hanan, E. J., Lupardus, P., Brown, D. G., Robinson, C., Siu, M., Lyssikatos, J. P., Romero, F. A., Zhao, G., Kellar, T., Mendonca, R., Ray, N. C., Goodacre, S. C., Crackett, P. H., McLean, N., Hurley, C. A., Yuen, P., Cheng, Y., Liu, X., Liimatta, M., Kohli, P. B., Nonomiya, J., Salmon, G., Buckley, G., Lloyd, J., Gibbons, P., Ghilardi, N., Kenny, J. R., & Johnson, A. (2019). discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signaling. Bioorganic & medicinal chemistry letters, 29(12), 1522–1531. http://access.bl.uk/ark:/81055/vdc_100081478540.0x000022